Evidence map›Paper›PMID 42664211›Full record

ArticlePLOS global public health2026

"One less thing to worry about": Barriers and facilitators of PrEP uptake among MSM in Karachi, Pakistan: A qualitative study.

Batool Fatima, Sarmad Soomar, Preet Katyara, Shariqa Batool, Syed Faisal Mahmood

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Batool FatimaDepartment of Community Health Sciences, Aga Khan University, Karachi, Pakistan.ORCID https://orcid.org/0000-0002-7079-8121
Sarmad SoomarSchool of Nursing and Midwifery, Aga Khan University, Karachi, Pakistan.
Preet KatyaraInternal Medicine, Henry Ford Hospital, Detroit, Michigan, United States of America.
Shariqa BatoolDepartment of Medicine, Aga Khan University, Karachi, Pakistan.
Syed Faisal MahmoodDepartment of Medicine, Aga Khan University, Karachi, Pakistan.ORCID https://orcid.org/0000-0002-3390-7659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Pakistan, MSM represent one of the key populations at risk of HIV, with rising rates of HIV compared to the general population and other key populations. Pre-exposure prophylaxis (PrEP) was rolled out in Pakistan in two of the most populated provinces, Sindh and Punjab, targeting key populations including MSM. However, only 23% of the high-risk population in Sindh and only 9% in Punjab used PrEP. A qualitative study with a descriptive exploratory design was conducted to explore the barriers, willingness, and preferred ways of using PrEP among Men who have Sex with Men (MSM) in Karachi, Sindh. In-depth interviews were conducted with six MSM in the outpatient setting of a tertiary care hospital in Karachi, where PrEP is prescribed and available for use in the MSM population. Participants reported lack of awareness, fear of stigma and discrimination, concerns about privacy and confidentiality, and financial and logistical challenges as barriers to their willingness and uptake of PrEP. Facilitators included awareness, accessibility, and availability of PrEP; perceived benefits of PrEP; affordability; social support; and experiences of professionalism and non-judgmental care in PrEP services. Participants recommended raising awareness at MSM social gatherings or on MSM dating applications such as Grindr, ensuring privacy, anonymity, and comfort by providing online consulting services and male care providers, the possibility of home testing and delivery of PrEP medication, and the need for emotional support and validation of concerns when needed. They also expressed a desire for PrEP with a longer shelf life or long-acting injections. This study provides insights into the enabling factors and roadblocks in the uptake of PrEP among MSM and provides an opportunity to refine Human Immunodeficiency Virus (HIV) prevention services.

Identifiers

PMID42664211
PMCPMC13524246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.